Aker BioMarine ASA – Registration of share capital increase

Reference is made to Aker BioMarine ASA's stock exchange announcement on 26 February 2026 regarding the result of the offer under the Employee Share Purchase Program and the related share capital increase.

The share capital increase pertaining to the Employee Share Purchase Program has today been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret). The new registered share capital of the company is NOK 526 341 156, divided into 87 723 526 shares, each with a par value of NOK 6.00. Upon registration with the Norwegian Central Securities Depository (VPS), the new shares will be listed on the Oslo Stock Exchange.

For further information, please contact Lars Jacobsen, General Counsel / SVP Mobile: +47 90 60 53 06 Email: lars.jacobsen@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine: Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.